Your browser doesn't support javascript.
loading
Preliminary Results From a Randomized Controlled Study for an App-Based Cognitive Behavioral Therapy Program for Depression and Anxiety in Cancer Patients.
Ham, Kyunghee; Chin, Siyung; Suh, Yung Jae; Rhee, Myungah; Yu, Eun-Seung; Lee, Hyun Jeong; Kim, Jong-Heun; Kim, Sang Wun; Koh, Su-Jin; Chung, Kyong-Mee.
Afiliación
  • Ham K; Department of Psychology, Yonsei University, Seoul, South Korea.
  • Chin S; Department of Psychology, Yonsei University, Seoul, South Korea.
  • Suh YJ; Department of Psychology, Yonsei University, Seoul, South Korea.
  • Rhee M; Department of Psychology, Yonsei University, Seoul, South Korea.
  • Yu ES; Department of Psychiatry, National Cancer Center, Goyang-si, South Korea.
  • Lee HJ; Department of Psychiatry and Behavioral Science, National Cancer Center, Goyang-si, South Korea.
  • Kim JH; Department of Psychiatry, National Cancer Center, Goyang-si, South Korea.
  • Kim SW; Department of Obstetrics and Gynecology, Women's Cancer Clinic, Yonsei University College of Medicine, Seoul, South Korea.
  • Koh SJ; Department of Hematology and Oncology, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, South Korea.
  • Chung KM; Department of Psychology, Yonsei University, Seoul, South Korea.
Front Psychol ; 10: 1592, 2019.
Article en En | MEDLINE | ID: mdl-31402881
ABSTRACT
Cancer patients experience various psychological and social difficulties, the most common being depression and anxiety. The purpose of this study was to develop and evaluate the effectiveness of an app-based cognitive behavioral therapy program for depression and anxiety in cancer patients. For this purpose, 63 participants who met the inclusion criteria were randomly assigned to either a mobile-application-based cognitive behavioral therapy program (HARUToday), a simple information-provision mobile-application-based program (HARUCard), or a waitlist control group. Self-report questionnaires including the Beck Depression Inventory, State-Trait Anxiety Inventory, Health-Related Quality of Life Scale, Dysfunctional Attitude Scale, and two computer tasks including the dot-probe task and the Implicit Association Test, were administered before and after 66 days of intervention. The results showed that the Beck Depression Inventory and State-Trait Anxiety Inventory scores of the cognitive behavioral therapy program (HARUToday) group decreased significantly after the intervention compared to the attention control (HARUCard) and waitlist control groups. However, there were no significant changes in scores of the Health-Related Quality of Life Scale and Dysfunctional Attitude Scale, and the two computer tasks. Such results suggest that a mobile-application-based cognitive behavioral therapy program may be an effective intervention for alleviating depression and anxiety, but not the general quality of life of cancer patients. Taking into consideration that psychosocial problems may not the topmost priority for cancer patients who are facing a chronic and possibly mortal disease, a mobile-application cognitive behavioral therapy program may be a possible solution for the alleviation of depression and anxiety in cancer patients who have many restraints in terms of time and space.
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Clinical_trials Idioma: En Revista: Front Psychol Año: 2019 Tipo del documento: Article País de afiliación: Corea del Sur

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Clinical_trials Idioma: En Revista: Front Psychol Año: 2019 Tipo del documento: Article País de afiliación: Corea del Sur